QS Batterymarch Financial Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

QS Batterymarch Financial Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$174K	Hold	2,400	–	–	﹤0.01%	697
2014 Q2	$150K	Sell	2,400 -19,950	-89%	-$1.21M	﹤0.01%	721
2014 Q1	$1.52M	Sell	22,350 -950	-4%	-$70K	0.03%	573
2013 Q4	$1.64M	Sell	23,300 -750	-3%	-$50.9K	0.03%	530
2013 Q3	$1.74M	Hold	24,050	–	–	0.04%	518
2013 Q2	$1.34M	Buy	+24,050	New	+$1.5M	0.03%	585

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QS Batterymarch Financial Management's BMRN Position: Q3 2014 in Review

QS Batterymarch Financial Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2014 at 2,400 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

QS Batterymarch Financial Management first reported a position in BMRN in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.74M in Q3 2013. 316 funds tracked by Wall St. Rank hold BMRN as of Q3 2014.

QS Batterymarch Financial Management held 2,400 shares of BioMarin Pharmaceuticals worth $174K as of Q3 2014.
QS Batterymarch Financial Management left its BioMarin Pharmaceuticals share count unchanged in Q3 2014.
BioMarin Pharmaceuticals made up ﹤0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #697 holding.
QS Batterymarch Financial Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's BioMarin Pharmaceuticals position peaked at $1.74M in Q3 2013.
316 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.